|Viral dynamics in human immunodeficiency virus type 1 infection|
X Wei, SK Ghosh, ME Taylor, VA Johnson, EA Emini, P Deutsch, ...
Nature 373 (6510), 117-122, 1995
|Antibody neutralization and escape by HIV-1|
X Wei, JM Decker, S Wang, H Hui, JC Kappes, X Wu, ...
Nature 422 (6929), 307-312, 2003
|Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes|
F Gao, E Bailes, DL Robertson, Y Chen, CM Rodenburg, SF Michael, ...
Nature 397 (6718), 436-441, 1999
|Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection|
P Borrow, H Lewicki, BH Hahn, GM Shaw, MB Oldstone
Journal of virology 68 (9), 6103-6110, 1994
|Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection|
BF Keele, EE Giorgi, JF Salazar-Gonzalez, JM Decker, KT Pham, ...
Proceedings of the National Academy of Sciences 105 (21), 7552-7557, 2008
|Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy|
X Wei, JM Decker, H Liu, Z Zhang, RB Arani, JM Kilby, MS Saag, X Wu, ...
Antimicrobial agents and chemotherapy 46 (6), 1896-1905, 2002
|AIDS as a zoonosis: scientific and public health implications|
BH Hahn, GM Shaw, KM De, Cock, PM Sharp
Science 287 (5453), 607-614, 2000
|High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR|
M Piatak, MS Saag, LC Yang, SJ Clark, JC Kappes, KC Luk, BH Hahn, ...
Science 259 (5102), 1749-1754, 1993
|Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus|
P Borrow, H Lewicki, X Wei, MS Horwitz, N Peffer, H Meyers, JA Nelson, ...
Nature medicine 3 (2), 205-211, 1997
|Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry|
JM Kilby, S Hopkins, TM Venetta, B DiMassimo, GA Cloud, JY Lee, ...
Nature medicine 4 (11), 1302-1307, 1998
|Chimpanzee reservoirs of pandemic and nonpandemic HIV-1|
BF Keele, F Van Heuverswyn, Y Li, E Bailes, J Takehisa, ML Santiago, ...
Science 313 (5786), 523-526, 2006
|HTLV-III infection in brains of children and adults with AIDS encephalopathy|
GM Shaw, ME Harper, BH Hahn, LG Epstein, DC Gajdusek, RW Price, ...
Science 227 (4683), 177-182, 1985
|High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection|
SJ Clark, MS Saag, WD Decker, S Campbell-Hill, JL Roberson, ...
New England Journal of Medicine 324 (14), 954-960, 1991
|Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS|
BR Starcich, BH Hahn, GM Shaw, PD McNeely, S Modrow, H Wolf, ...
Cell 45 (5), 637-648, 1986
|Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus|
HX Liao, R Lynch, T Zhou, F Gao, SM Alam, SD Boyd, AZ Fire, KM Roskin, ...
Nature 496 (7446), 469-476, 2013
|Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection|
JF Salazar-Gonzalez, MG Salazar, BF Keele, GH Learn, EE Giorgi, H Li, ...
Journal of Experimental Medicine 206 (6), 1273-1289, 2009
|Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120|
CA Derdeyn, JM Decker, JN Sfakianos, X Wu, WA O'Brien, L Ratner, ...
Journal of virology 74 (18), 8358-8367, 2000
|Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV|
G Pantaleo, JF Demarest, H Soudeyns, C Graziosi, F Denis, ...
Nature 370 (6489), 463-467, 1994
|Acute HIV-1 infection|
MS Cohen, GM Shaw, AJ McMichael, BF Haynes
New England Journal of Medicine 364 (20), 1943-1954, 2011
|Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome|
GM Shaw, BH Hahn, SK Arya, JE Groopman, RC Gallo, F Wong-Staal
Science 226 (4679), 1165-1171, 1984